A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy

NCT04230044 · clinicaltrials.gov ↗

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Partial-onset Seizures

Interventions

DRUG: Perampanel

Sponsor

Eisai Co., Ltd.